ATE542890T1 - Produktivitätserhöhender proteinfaktor, neue zelllinien und verwendungen davon - Google Patents

Produktivitätserhöhender proteinfaktor, neue zelllinien und verwendungen davon

Info

Publication number
ATE542890T1
ATE542890T1 AT06807777T AT06807777T ATE542890T1 AT E542890 T1 ATE542890 T1 AT E542890T1 AT 06807777 T AT06807777 T AT 06807777T AT 06807777 T AT06807777 T AT 06807777T AT E542890 T1 ATE542890 T1 AT E542890T1
Authority
AT
Austria
Prior art keywords
productivity
cell lines
new cell
increase protein
protein factor
Prior art date
Application number
AT06807777T
Other languages
English (en)
Inventor
Volker Sandig
Ingo Jordan
Elisabeth Brundke
Original Assignee
Probiogen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiogen Ag filed Critical Probiogen Ag
Application granted granted Critical
Publication of ATE542890T1 publication Critical patent/ATE542890T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/075—Adenoviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651—Methods of production or purification of viral material
    • C12N2710/16652—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT06807777T 2005-11-08 2006-11-08 Produktivitätserhöhender proteinfaktor, neue zelllinien und verwendungen davon ATE542890T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05110453A EP1783210A1 (de) 2005-11-08 2005-11-08 Proteinfaktoren zur Erhöhung der Produktivität, neue Zelllinien und deren Verwendungen
US75015605P 2005-12-14 2005-12-14
PCT/EP2006/068234 WO2007054516A1 (en) 2005-11-08 2006-11-08 Productivity augmenting protein factor, novel cell lines and uses thereof

Publications (1)

Publication Number Publication Date
ATE542890T1 true ATE542890T1 (de) 2012-02-15

Family

ID=35985267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06807777T ATE542890T1 (de) 2005-11-08 2006-11-08 Produktivitätserhöhender proteinfaktor, neue zelllinien und verwendungen davon

Country Status (20)

Country Link
US (1) US8815540B2 (de)
EP (2) EP1783210A1 (de)
JP (1) JP5468780B2 (de)
KR (1) KR101311973B1 (de)
CN (1) CN101356265B (de)
AT (1) ATE542890T1 (de)
AU (1) AU2006310999B2 (de)
BR (1) BRPI0618369B1 (de)
CA (1) CA2628689C (de)
CY (1) CY1112734T1 (de)
DK (1) DK1945760T3 (de)
ES (1) ES2380975T3 (de)
IL (1) IL191327A (de)
MY (1) MY147959A (de)
NZ (1) NZ568482A (de)
PL (1) PL1945760T3 (de)
PT (1) PT1945760E (de)
RU (1) RU2449015C2 (de)
SI (1) SI1945760T1 (de)
WO (1) WO2007054516A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2265712B1 (de) * 2008-03-04 2014-07-23 ProBioGen AG Zelllinie aus rousettus als wirtszelle zur pathogenamplifikation
EP2098590A1 (de) * 2008-03-04 2009-09-09 ProBioGen AG Zelllinie des Rosettenflughundes als Hostzelle für pathogene Verstärkung
EP2199385A1 (de) * 2008-12-16 2010-06-23 ProBioGen AG Spezifische und persistente Aktivierung der Hitzeschockreaktion in Zelllinien mittels eines viralen Faktors
CN108795983A (zh) * 2018-06-28 2018-11-13 深圳市疾病预防控制中心（深圳市卫生检验中心、深圳市预防医学研究所） 一种RXRα蛋白稳定高表达细胞系及其制备方法
WO2026041811A1 (en) 2024-08-23 2026-02-26 Transgene Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804413A (en) * 1992-07-31 1998-09-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Herpes simplex virus strains for gene transfer
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
EP1075532A1 (de) * 1998-05-01 2001-02-14 Genzyme Corporation Teilweise deletierte adenovirusvektoren
WO1999057296A1 (en) * 1998-05-01 1999-11-11 Genzyme Corporation Partially deleted adenoviral vectors
CA2448908C (en) * 2001-05-30 2008-03-18 Transgene S.A. Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
EP1528101A1 (de) * 2003-11-03 2005-05-04 ProBioGen AG Immortalisierte Vogel-Zelllinien für die Produktion von Viren
AU2006310341B2 (en) * 2005-11-04 2011-01-06 Novartis Vaccines And Diagnostics Limited Influenza vaccines extemporaneously adsorbed to aluminium adjuvants

Also Published As

Publication number Publication date
CN101356265B (zh) 2013-04-03
PT1945760E (pt) 2012-03-28
EP1945760A1 (de) 2008-07-23
KR101311973B1 (ko) 2013-09-27
IL191327A (en) 2013-03-24
AU2006310999A1 (en) 2007-05-18
JP5468780B2 (ja) 2014-04-09
PL1945760T3 (pl) 2012-05-31
CA2628689A1 (en) 2007-05-18
WO2007054516A1 (en) 2007-05-18
CN101356265A (zh) 2009-01-28
BRPI0618369A2 (pt) 2011-08-30
RU2449015C2 (ru) 2012-04-27
EP1945760B1 (de) 2012-01-25
RU2008122920A (ru) 2009-12-20
SI1945760T1 (sl) 2012-03-30
NZ568482A (en) 2011-06-30
DK1945760T3 (da) 2012-03-05
EP1783210A1 (de) 2007-05-09
BRPI0618369B1 (pt) 2022-04-12
CA2628689C (en) 2014-02-25
MY147959A (en) 2013-02-15
KR20080068104A (ko) 2008-07-22
JP2009514544A (ja) 2009-04-09
AU2006310999B2 (en) 2012-04-12
ES2380975T3 (es) 2012-05-22
US8815540B2 (en) 2014-08-26
CY1112734T1 (el) 2016-02-10
US20120164727A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
CY2025002I1 (el) Τροποποιημενο πολυπεπτιδιο παραγοντα ix, οι χρησεις του και μια μεθοδος για την παραγωγη του
ATE496900T1 (de) Isoxazoline für die bekämpfung von wirbellosen schädlingen
MY169472A (en) Refolding of recombinant proteins
CY1109232T1 (el) Νεα καρβαμυλιωμενη ερο και μεθοδος παραγωγης της
SG169390A1 (en) Expression system
DK3050963T3 (da) Fremgangsmåde til fremstilling af polypeptid ved regulering af arrangement
DE602007009654D1 (de) Neue polyarylenzusammensetzung und damit hergestellte artikel
ATE442450T1 (de) Neue expressionswerkzeuge für multiproteinanwendungen
DE602004023140D1 (de) Rhamnose-induzierbares Expressionssystem
CY1112734T1 (el) Πρωτεϊνικος παραγοντας αυξησης παραγωγικοτητας, πρωτοτυπες κυτταρικες σειρες και χρησεις αυτων
ATE495157T1 (de) Neue aminoalkohol-substituierte aryldihydroisochinolinone, herstellungsverfahren und ihre verwendung als medikamente
DE602004023757D1 (de) Methode zur reinigung von fsh
DK2460823T3 (da) Modificeret sekretionssystem til øget ekspression af polypeptider ibakterier
DE502004004377D1 (de) Ventil zum steuern von flüssigkeiten
DE112008001904A5 (de) Vorrichtung zur Blasformung von Behältern
DK1599694T3 (da) Gasreguleringsarmatur
DE602006004888D1 (de) 6-methoxy-2,6-dimethyloctanal und verwendung davon als duftstoffbestandteil
ATE301108T1 (de) Verwendung eines magnesiazirkoniasteins
ATE549351T1 (de) Chimärer peptidantagonist für gpcr135 oder gpcr142
ATE553190T1 (de) Neue halogenase
ATE500211T1 (de) Neue 1-methoxy-2-phenylethene zur herstellung von 5-carboxaldehyd-2,3-dihydrobenzoxepinen
FI20030080L (fi) Korvausilmaventtiili
ZA200800267B (en) Method for the identification of proteins folding inhibitors
DE502006003790D1 (de) Gasregelgerät
ATE426046T1 (de) Stoffliche nutzung von biogas